JW Pharmaceutical Corporation (KRX:001060)

JW Pharmaceutical Revenue

In the year 2025, JW Pharmaceutical had annual revenue of 775.30B KRW with 7.77% growth. JW Pharmaceutical had revenue of 198.94B in the quarter ending December 31, 2025, with 5.90% growth.

• Revenue: 775.30B
• Revenue Growth: +7.77%
• P/S Ratio: 0.94
• Revenue / Employee: 725.93M
• Employees: 1,068
• Market Cap: 729.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	775.30B	55.92B	7.77%
Dec 31, 2024	719.38B	-29.15B	-3.89%
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%